We will post news items relating to society activity under this section.
21 January 2020
Invitation to tender for BNOS 2021 and BNOS 2022 meetings
BNOS council is delighted to invite interested oncology departments to tender to host the annual conferences in 2021 and 2022. We encourage applications from a team based around a neuro-oncology MDT and comprised of relevant stakeholders including clinicians and allied health professionals.
We anticipate that each conference will take place at the end of June in the respective year; and will run for three days from Wednesday to Friday, typically ending after lunch.
The successful teams will be supported by a Professional Conference Organiser (PCO) engaged by BNOS to identify a suitable venue and organise logistics for the annual conference for which they are appointed including social events.
14 January 2020
Invitation to apply for upcoming vacancies
The British Neuro-Oncology Society (BNOS) is seeking to recruit the following Council representatives:
- – 1x Neuropathology Representative
- – 1x Neurology Representative
- – 1x Patient Representative
As several current Council members are approaching the end of their final term, we are keen to hear from any individuals who would be like to be considered for the above voluntary posts on Council.
Each post will commence on the 1 August 2020 and will be for an initial three-year term, with the possibility of re-election to a further three-year term.
As a Council member you will assist in Council’s remit of controlling the management of the Society and implementing the Society’s policies in line with BNOS’ Mission: To promote high-quality multi- disciplinary neuro-oncology research, education and patient-centred care.
All Council members are expected to attend Council meetings, which are held three times yearly within the UK; as well as the Annual General Meeting (AGM) which is held during the UK based Annual Conference.
Those wishing to be considered should submit an expression of interest of up to one-page maximum outlining which post they would like to be considered for, and how they feel they could contribute to Council and to BNOS. It is not required for applicants to be current BNOS members at the time of applying, however, if successfully appointed postholders will be expected to join the BNOS membership.
Please contact Becci Pearson, BNOS Administrator, email@example.com, with your expression of interest by no later than 28 February 2020, 5pm.
Elections for the above posts will take place via a confidential online voting system, open to BNOS members only, details of which will be announced in due course.
27 November 2019
Brain Tumour Awareness Week: acknowledging commitment from all angles
The 13th International Brain Tumour Awareness Week was held from Saturday, 26th October to Saturday, 2nd November 2019.
As part of this, the Children’s Brain Tumour Drug Delivery Consortium (CBTDDC) ran a series of articles on individuals working in very different capacities within the brain tumour field. Here we provide a taster of this coverage. You can read the full-length articles here: http://www.cbtddc.org/news/brain-tumour-awareness-week-2019.aspx
Nicola Farrer from the University of Oxford describes her lab’s work in the field of metals in medicine, designing new treatments and ways of delivering these treatments using physical activation methods. Nicola also talks about how she benefitted from the CBTDDC’s first Workshop on Drug Delivery to the Brain. Our second workshop is open for registrations – http://www.cbtddc.org/workshop/index.aspx
Sharon Kane, CEO of charity Funding Neuro, talks of how she was inspired to do everything she could to support the clinicians and researchers to try and find a treatment for brain tumours. Funding Neuro is part-funding a clinical trial using convection-enhanced delivery to deliver a combination therapy directly into Diffuse Intrinsic Pontine Gliomas.
Ruman Rahman from the University of Nottingham describes his optimism for future advances in the development of innovative ways to deliver more effective doses of new drugs into the brain. He also notes how the CBTDDC benefitted his own research team by helping to initiate a collaboration with researchers at Johns Hopkins University (USA).
Miroslaw Janowski from the University of Maryland discusses his work within the Society for Image Guided Neurointerventions (SIGN), set up to foster therapies of brain and spinal cord disorders while preventing toxicity to the rest of the body. Miroslaw also discusses SIGN’s collaboration with CBTDDC in developing and delivering the annual SIGN conference.
Cesare Spadoni tells his tale from a parent’s perspective, how losing his daughter to cancer led him to set up the charity aPODD (accelerating Paediatric Oncology Drug Development). Cesare’s next step took him into biotech, where he co-founded Oncoheroes Biosciences to focus exclusively on childhood cancer drug development.
David Walker, Chair of the CBTDDC at the University of Nottingham, talks about how we are now seeing a change in attitude and awareness of the importance of drug delivery in brain tumours, and the role that the CBTDDC is playing in this exciting research climate.
8 February 2019
FREE ebrain access to BNOS members
In November 2018 BNOS became a Member Society of the Joint Neurosciences Council (JNC) and is delighted to have the opportunity to participate in joint collaboration and discussions with a number of key UK based neuroscience organisations.
New and existing BNOS members will be offered free login access to ebrain from February 2019 onwards. Login details have now been sent to existing members.
If you are not already a member, we warmly invite you to join the society, and benefit from ebrain access, in addition to significant meeting registration discounts at our BNOS 2019 meeting in London, 3rd – 5th July 2019.
All Party Parliamentary Group on Brain Tumours
Brain Tumours – a cost too much to bear?
In early 2018, the All-Party Parliamentary Group on Brain Tumours (APPGBT) launched its first-ever Inquiry. This sought to learn more about the economic and social impacts of a brain tumour diagnosis in order to shine a light on these issues, many of which, although seemingly invisible, are felt deeply.
Please visit Brain Tumour Research for further information.
Download a copy of the report Brain Tumours – a cost too much to bear?
22 November 2018
A statement from the British Neuro-oncology Society
with support from:
The Brain Tumour Charity, Brain Tumour Research, brainstrust, Brain Tumour Action, Brain Tumour Support, Brain Tumour Research and Support Across Yorkshire, and the International Brain Tumour Alliance (IBTA)
The British Neuro-Oncology Society (BNOS) is the UK national learned society for all disciplines within the field of brain and CNS tumours. In accordance with our goals of providing the very best research, care and support for people affected by brain and CNS tumours – many of which are rare cancers – we ask the UK Government to urgently clarify their intentions on the status of European Reference Networks (ERNs) in the UK, post-Brexit, and what progress has been made in relation to this specifically since the publication of the “Collaboration on science and innovation: a future partnership paper”.
We also urge the European Commission to clarify their intentions on the status of European Reference Networks in the UK, post-Brexit.
17 May 2018
New funding for Brain Tumour research
In February 2018, the government announced a £45 million brain cancer research fund, to include a Cancer Research UK contribution of £25 million and a government contribution of £20 million, to be rolled out over five years. Plans to double the initial government investment to £40 million have been announced on the 13th of May, and Cancer Research UK, in partnership with Stand Up to Cancer has announced an additional £10 million fund.
With the announced increase, a total research package of £75 million will be made available, through the National Institute for Health Research and Cancer Research UK over a five year period.
BNOS has been campaigning together with brain tumour charities, patient organisations and high profile patrons for an increase in brain tumour research investment for many years and we welcome this announcement.
We will endeavour to keep the neuro-oncology community informed of funding opportunities, when they become available.
Current open funding calls emanating from this commitment are:
- a Cancer Research UK call focused on brain tumour research in partnership with The Brain Tumour Charity,
- a Stand up to Cancer-CRUK call for translation research on paediatric brain cancer , and
- NIHR funding calls with brain tumour highlight notice.
Updated November 2019